JFL Life Sciences (NSE:JFLLIFE) Institutional Ownership: 0.00% (As of Aug. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
76 GF Score
Price ₹13.85
GF Value ₹36.39
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is JFL Life Sciences Institutional Ownership?

JFL Life Sciences NSE:JFLLIFE +1.47% 76 Institutional Ownership is 0.00% as of Aug. 10, 2026. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 76/100 and a GF Value™ of ₹36.39 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, JFL Life Sciences's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, JFL Life Sciences's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, JFL Life Sciences's Float Percentage Of Total Shares Outstanding is 0.00%.

JFL Life Sciences Institutional Ownership Historical Data

* Premium members only.

The historical data trend for JFL Life Sciences's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences Institutional Ownership Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Institutional Ownership
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Institutional Ownership Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:JFLLIFE
76GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JFL Life Sciences Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
JFL Life Sciences (NSE:JFLLIFE) has a Institutional Ownership of 0.00% as of Aug. 10, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on JFL Life Sciences and its competitors.
Is JFL Life Sciences' Institutional Ownership too high?
JFL Life Sciences' current Institutional Ownership is 0.00%. Overall, JFL Life Sciences has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' Institutional Ownership compare to ZTS?
JFL Life Sciences' Institutional Ownership of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on JFL Life Sciences and its competitors. JFL Life Sciences's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹36.39, compared to a current price of ₹13.85 — trading 61.9% below its estimated fair value. The current Institutional Ownership is 0.00%. JFL Life Sciences' overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current Institutional Ownership is 0.00% as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹13.85 is trading 61.9% below its estimated GF Value™ of ₹36.39. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • Institutional Ownership: 0.00%
  • GF Value™: ₹36.39 vs. price of ₹13.85 (61.9% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
76GF Score

Get the complete analysis for NSE:JFLLIFE

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.85
Price
₹36.39
GF Value